Posticy
Posticy
Boost your SEO with Backlinks that are worth it
YOUR AD HERE
SR Ranko
SR Ranko
Turn scattered startup information into focused action.
YOUR AD HERE
SR Booster
SR Booster
Submit your startup to 120+ top directories.
YOUR AD HERE

New Owner

Biogen Idec - Convergence Pharmaceuticals

Biogen Idec acquires Convergence Pharmaceuticals

Announced: January 11, 2015

Type:           Acquisition
Disposition: Subsidiary
Status:         Complete

Amount:       $ 675,000,000

Acquisition News

Add News

Date Title
Jan 12, 2015 Fierce Biotech - Biogen Idec grabs Convergence, neuropathic pain portfolio in $675M buyout
Biogen Idec grabs Convergence, neuropathic pain portfolio in $675M buyout
Jan 11, 2015 Boston Tech Flash - Biogen buys UK-based neuropathic pain drug developer for up to $675M - Boston Business Journal
Biogen buys UK-based neuropathic pain drug developer for up to $675M - Boston Business Journal

Biogen Idec Other Acquisitions

Add Acquisition

Date Acquired Amount
May 18, 2017
Remedy Pharmaceuticals
Remedy Pharmaceuticals
 $ 120,000,000
Feb 14, 2014
Stromedix
Stromedix
 $ 75,000,000
Feb 01, 2013
Tysabri
Tysabri
 Undisclosed amount
Jan 04, 2007
Syntonix Pharmaceuticals
Syntonix Pharmaceuticals
 $ 120,000,000
May 31, 2006
Fumapharm
Fumapharm
 Undisclosed amount
View more acquisitions »
ELECTE
ELECTE
For Growing Companies Looking for Answers, Not Consultants.
YOUR AD HERE